Search research articles
Contact Us
Filters
Showing results (21-30 of 242) with videos related to
Page
of 25
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model
Charlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, et al.
Journal of Cancer
|
November 28, 2019
Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis
Anna-Maria Goebel, Astrid K Gnekow, Daniela Kandels, et al.
The Journal of Pathology. Clinical Research
|
December 9, 2020
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
Baptiste Ameline, Michal Kovac, Michaela Nathrath, et al.
Anti-Cancer Drugs
|
September 4, 2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells
Dennis Wegener, Hedwig E Deubzer, Ina Oehme, et al.
IEEE Transactions on Medical Imaging
|
September 13, 2022
Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids
Yannick Berker, Dina ElHarouni, Heike Peterziel, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
Johanna Senger, Jelena Melesina, Martin Marek, et al.
Hereditary Cancer in Clinical Practice
|
June 12, 2023
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma
Michaela Kuhlen, Mariola Monika Golas, Tina Schaller, et al.
Redox Biology
|
October 8, 2018
The enzyme activity of histone deacetylase 8 is modulated by a redox-switch
Niklas Jänsch, Christian Meyners, Marius Muth, et al.
International Journal of Cancer
|
October 2, 2012
HDAC11 is a novel drug target in carcinomas
Hedwig E Deubzer, Marie C Schier, Ina Oehme, et al.
Journal of Pediatric Hematology/Oncology
|
May 14, 2010
Sorafenib plus valproic acid for infant spinal glioblastoma
Christopher Alan Rokes, Mark Remke, Nandita Guha-Thakurta, et al.
Page
of 25
Search research articles
Search
Showing results (21-30 of 242) with videos related to
Sort By:
Page
of 25
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2022
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model
Charlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, et al.
Journal of Cancer
|
November 28, 2019
Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis
Anna-Maria Goebel, Astrid K Gnekow, Daniela Kandels, et al.
The Journal of Pathology. Clinical Research
|
December 9, 2020
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
Baptiste Ameline, Michal Kovac, Michaela Nathrath, et al.
Anti-Cancer Drugs
|
September 4, 2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells
Dennis Wegener, Hedwig E Deubzer, Ina Oehme, et al.
IEEE Transactions on Medical Imaging
|
September 13, 2022
Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids
Yannick Berker, Dina ElHarouni, Heike Peterziel, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
Johanna Senger, Jelena Melesina, Martin Marek, et al.
Hereditary Cancer in Clinical Practice
|
June 12, 2023
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma
Michaela Kuhlen, Mariola Monika Golas, Tina Schaller, et al.
Redox Biology
|
October 8, 2018
The enzyme activity of histone deacetylase 8 is modulated by a redox-switch
Niklas Jänsch, Christian Meyners, Marius Muth, et al.
International Journal of Cancer
|
October 2, 2012
HDAC11 is a novel drug target in carcinomas
Hedwig E Deubzer, Marie C Schier, Ina Oehme, et al.
Journal of Pediatric Hematology/Oncology
|
May 14, 2010
Sorafenib plus valproic acid for infant spinal glioblastoma
Christopher Alan Rokes, Mark Remke, Nandita Guha-Thakurta, et al.
Page
of 25